NEW YORK (GenomeWeb) – Becton Dickinson today reported a 46 percent increase year over year in fiscal 2016 first quarter revenues, with growth in its medical segment topping 92 percent.

For the three months ended Dec. 31, BD reported revenues of $2.99 billion compared to $2.05 billion in the same quarter last year, but below analysts' consensus estimate of $3.03 billion. On a currency-neutral basis, revenues increased about 54 percent year over year, BD said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Sponsored by

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.